Buy-side firms in the APAC region are largely unprepared for OTC clearing mandates, says report
Buy-side firms in the Asia-Pacific region are largely
unprepared for the future implementation of OTC derivatives
clearing, according to research from a global consultancy firm,
writes Joe Parsons.
A new report from GreySpark Partners found most buy-side
firms in the region have not yet selected a clearing broker for
uncleared OTC derivatives and are not ready for the complexity
of the regulations.
Though brokers are not in place, the companies are asking banks
to provide them with the same central clearing value-added
services available to the buy-side in the EU and US.
This article is available exclusively to subscribers
Please log in to continue reading.
Not yet a subscriber?
Click here to take a free trial.
Already have an account? |
Please fill in your details below and a customer service representative will contact you.